Over 30% Covaxin takers reported adverse events: Study

Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......

Covid vax didn't increase risk of sudden death among young: Govt

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the......

Covaxin safe for children: Bharat Biotech

IMAGE: An Auxiliary Nurse Midwife healthcare worker inoculating a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination campaign at Margomunda, in Deoghar, Jharkhand,......

Covaxin gets nod for use in children above 12 years with riders

The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions, official......